Posters

      Characterization of the Vitrocell® Cloud SEQ 24 System and its Application in Exposure to Aerosolized Bortezomib and Ibuprofen

      Steiner, S.; Ferreira, S.; Morelli, M.; Baldi, A.; Kuczaj, A. K.; Frentzel, S.; van der Toorn, M.; Peitsch, M.; Hoeng, J.
      Conference date
      May 9, 2019
      Conference name

      Respiratory Drug Delivery Europe (RDD)
      Link to more information
      Topic
      Summary

      Introduction: The Vitrocell® Cloud is an in vitro aerosol exposure system specifically designed for exposing cell cultures to liquid aerosols. It consists of a cuboidal aerosol chamber below which a multi-well base module is located. The temperature-controlled base module provides reservoirs for cell culture medium and is designed to hold cell cultures grown on Transwell inserts at the air-liquid interface. Aerosols for exposures are generated from a defined volume, usually 200 µL, of a test solution by the action of a vibrating mesh nebulizer mounted on top of the aerosol chamber. The aerosol generated by the nebulizer forms a cloud within the aerosol chamber, distributes evenly above the surface of the base module and subsequently deposits on cell cultures present therein. By means of covers that can be moved over groups of four exposure chambers, the newly designed Vitrocell® Cloud SEQ 24 allows exposure of 24 cell cultures of the 24-well format to up to six different doses without opening the aerosol chamber and hence, is highly suitable for dose-response testing. In this work, we present a quantitative characterization of aerosol deposition in the Vitrocell® Cloud SEQ 24 system. We provide evidence that the Vitrocell® Cloud SEQ 24 is fit for purpose for cell culture exposures and describe biological responses of human bronchial organotypic cell cultures to Bortezomib and Ibuprofen exposure within the system. Conclusions: Our results demonstrate that the Vitrocell® Cloud SEQ 24 is fit for purpose for performing test exposures using aerosols generated from small volumes of liquids and suspensions; Test aerosols deposit uniformly across the 24 cell culture inserts, the inter-repetition variations in the deposited aerosol massed are low and the so far available results on the biological responses to Ibuprofen and Bortezomib exposures confirm that the system is a suitable tool for testing aerosolized solutions for their bioactivity. The results on proteasome activity and cytokine secretion will further substantiate this finding. The good system performance reported here, the system’s applicability for simple and efficient multiple dosing as well as the small volumes of test solution required (200 μL) render the Vitrocell® Cloud SEQ 24 particularly interesting for the initial activity screening of candidate drugs that have been synthesized in small amounts only.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.